October 28, 2019 / 11:27 AM / 21 days ago

BRIEF-CRISPR Therapeutics Reports Q3 Earnings Per Share $2.40

Oct 28 (Reuters) - CRISPR Therapeutics AG:

* CRISPR THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS

* Q3 2019 TOTAL COLLABORATION REVENUE $211.9 MILLION VERSUS $0.6 MILLION FOR Q3 2018

* Q3 EARNINGS PER SHARE $2.40

* CRISPR THERAPEUTICS - Q3 REVENUE INCREASE PRIMARILY DRIVEN BY COLLABORATION AGREEMENT WITH VERTEX

* Q3 EARNINGS PER SHARE VIEW $-0.95, REVENUE VIEW $6.2 MILLION — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below